HPRA Drug Safety Newsletter Edition 86

Download: hpra-drug-safety-newsletter-edition-86.pdf 297 KB

 The latest edition of the HPRA Drug Safety Newsletter (DSN) includes important updates to support the safe and appropriate use of the following medicines:

Esmya 5mg Tablets (Ulipristal acetate)
Important new warnings of serious liver injury and recommendations for liver monitoring

Xofigo (radium-223 dichloride)
Contraindicated in combination with Zytiga (abiraterone acetate) and prednisone/prednisolone

Updated contraceptive advice for male patients

Oral Retinoids
Outcome of EU review and updated warnings

Zinbryta (daclizumab beta)
EMA recommends immediate suspension and recall

« Back